Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Y.H. Park, K-H. Lee, J. Sohn, K.S. Lee, K.H. Jung, J.H. Kim, K.H. Lee, J.S. Ahn, T-Y. Kim, G.M. Kim, I.H. Park, S-B. Kim, S.H. Kim, H.S. Han, Y-H. Im, J.H. Ahn, J-Y. Kim, | ||||||||||||
Title | A phase II trial of pan-HER inhibitor Poziotinib, in patients with HER2-positive metastatic breast cancer who have received at least two prior HER2-directed regimens: The results of NOV120101-203 trial | ||||||||||||
|
|||||||||||||
URL | https://www.annalsofoncology.org/article/S0923-7534(20)37661-4/fulltext | ||||||||||||
Abstract Text | Ann Oncol 2017, Vol 28, Suppl 5, Abstract # 237O |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|